Inrebic (fedratinib capsules) — Cigna
Myeloid or Lymphoid Neoplasms with eosinophilia and JAK2 rearrangement
Initial criteria
- Patient is age ≥ 18 years AND
- Patient has eosinophilia AND
- Tumor has a Janus Associated Kinase 2 (JAK2) rearrangement
Approval duration
1 year